6Borrow P H, Lewicki B H, Hahn G M, et al. Virus-specific CD8^+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol,1994, 68:6103-6110
7Musey L J, Hughes T, Schacker T, et al. Cytotoxic-T-celi responses,viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med, 1997, 337: 1267-1274
8Novitsky V, Smith U R, Gilbert P, et al. Human immunodeficiency virus type I subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol, 2002, 76 (11): 5435-5451
9Williamson A L, Marals D, Passmore J A, et al. Human papillomavirus (HPV) infection in Southern Africa: prevalence, immunity,and vaccine prospects. IUBMB Life, 2002, 53 (4-5): 253-258
10Mashishi T, Loubser S, Hide W, et al. Conserved domains of subtype C Nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions. AIDS Res Hum Retroviruses, 2001, 17 (17): 1681-1687
